LEGN
Price
$31.95
Change
-$0.41 (-1.27%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
5.97B
38 days until earnings call
NNVC
Price
$1.51
Change
+$0.06 (+4.14%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
25.27M
47 days until earnings call
Interact to see
Advertisement

LEGN vs NNVC

Header iconLEGN vs NNVC Comparison
Open Charts LEGN vs NNVCBanner chart's image
Legend Biotech
Price$31.95
Change-$0.41 (-1.27%)
Volume$11.39K
Capitalization5.97B
NanoViricides
Price$1.51
Change+$0.06 (+4.14%)
Volume$4.4K
Capitalization25.27M
LEGN vs NNVC Comparison Chart in %
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LEGN vs. NNVC commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEGN is a Hold and NNVC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (LEGN: $32.36 vs. NNVC: $1.45)
Brand notoriety: LEGN and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEGN: 134% vs. NNVC: 192%
Market capitalization -- LEGN: $5.9B vs. NNVC: $26.15M
LEGN [@Biotechnology] is valued at $5.9B. NNVC’s [@Biotechnology] market capitalization is $26.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEGN’s FA Score shows that 0 FA rating(s) are green whileNNVC’s FA Score has 1 green FA rating(s).

  • LEGN’s FA Score: 0 green, 5 red.
  • NNVC’s FA Score: 1 green, 4 red.
According to our system of comparison, both LEGN and NNVC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEGN’s TA Score shows that 4 TA indicator(s) are bullish while NNVC’s TA Score has 6 bullish TA indicator(s).

  • LEGN’s TA Score: 4 bullish, 4 bearish.
  • NNVC’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NNVC is a better buy in the short-term than LEGN.

Price Growth

LEGN (@Biotechnology) experienced а +0.43% price change this week, while NNVC (@Biotechnology) price change was +1.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.02%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

LEGN is expected to report earnings on Nov 24, 2025.

NNVC is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($5.97B) has a higher market cap than NNVC($25.3M). NNVC YTD gains are higher at: 1.399 vs. LEGN (-0.553). NNVC has higher annual earnings (EBITDA): -8.95M vs. LEGN (-260.04M). LEGN has more cash in the bank: 968M vs. NNVC (2.54M). NNVC has less debt than LEGN: NNVC (1.5M) vs LEGN (388M). LEGN has higher revenues than NNVC: LEGN (797M) vs NNVC (0).
LEGNNNVCLEGN / NNVC
Capitalization5.97B25.3M23,609%
EBITDA-260.04M-8.95M2,904%
Gain YTD-0.5531.399-40%
P/E RatioN/AN/A-
Revenue797M0-
Total Cash968M2.54M38,065%
Total Debt388M1.5M25,867%
FUNDAMENTALS RATINGS
NNVC: Fundamental Ratings
NNVC
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LEGNNNVC
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
O59.29-0.17
-0.29%
Realty Income Corp
IFS40.12-0.69
-1.69%
Intercorp Financial Services
LVWR4.79-0.20
-4.01%
LiveWire Group
FVCB12.11-0.63
-4.95%
FVCBankcorp
COCH0.85-0.06
-6.59%
Envoy Medical

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with TNGX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then TNGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
-4.03%
TNGX - LEGN
38%
Loosely correlated
-3.68%
AXON - LEGN
37%
Loosely correlated
+1.11%
CLDX - LEGN
37%
Loosely correlated
-2.89%
CRSP - LEGN
35%
Loosely correlated
-4.72%
RXRX - LEGN
35%
Loosely correlated
-6.33%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with TYRA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then TYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+0.69%
TYRA - NNVC
33%
Loosely correlated
-3.01%
GOSS - NNVC
32%
Poorly correlated
-4.15%
MRUS - NNVC
31%
Poorly correlated
-0.07%
LEGN - NNVC
30%
Poorly correlated
-4.03%
KYTX - NNVC
30%
Poorly correlated
-3.44%
More